Study to Evaluate the Efficacy and Safety of PF-07055480 / Giroctocogene Fitelparvovec Gene Therapy in Moderately Severe to Severe Hemophilia A Adults
Clinical trial NCT04370054 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04370054
- Sponsor
- Pfizer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-18
- Primary completion
- 2024-06-17
- Enrollment
- 77
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.